Researchers from the University of Leeds have revealed the structure of a virus which affects kidney and bone marrow transplant patients in near-atomic levels of detail for the first time.
This detailed information serves as a molecular-level structural visualisation, allowing scientists to study several potential targets for antiviral therapies or drugs.
In order to create a drug which can target viruses, researchers need to know what the virus looks like. With this knowledge, they can target chemical compounds at it in such a way that they bond with it precisely, stopping the virus from working. The more detailed the structure they have to work with, the more precision they can apply.
A research paper announcing the new structures has been published in the journal Structure. The level of detail in the image allows us to see features on the virus as tiny as ~3 Ångströms wide. One Ångström is equivalent to one ten-billionth of a metre or 0.1 nanometre. The structure is so small it cannot be seen by the naked eye.
Astbury Centre PhD researcher Dan Hurdiss, lead author of the paper, said: “Our structures provide the clearest picture to date of the infectious virus particle. This detailed information serves as a structural roadmap, allowing us to visualise several potential targets for antiviral therapies.
“These may include drugs which block BKV from entering our cells or which prevent proper assembly of the virus particle. Going forward, these structures may also be used to identify how antibodies from patients with other diseases recognise the BKV virus particle and thus aid in the development of a vaccine.”
About 80% of the world’s adult population is infected with BKV, but the virus rarely causes illness in people with a healthy immune system. However, in immunocompromised individuals, BKV can ‘reactivate’ and cause serious diseases.
Two such examples of BKV-associated diseases are polyomavirus-associated nephropathy (PVAN) and haemorrhagic cystitis (HC) which affect kidney and bone marrow transplant recipients respectively.
Around 10% of people who receive a kidney transplant will suffer from PVAN and up to 90% of these will go on to have their transplant organs rejected. At present, there are limited treatment options available for individuals suffering from BKV associated diseases.
The new structures will give hope to sufferers, by giving scientists a better-quality research tool to work with.
The structures were created using the cryo-electron microscopy method, which won a Nobel Prize in 2017, by freezing infectious BKV particles and taking thousands of images using the microscopes. These two-dimensional images were then combined computationally to produce a high-resolution, three-dimensional view of the virus.
“Without that detail, scientists sometimes struggled to understand the structure of biological molecules and how they function, especially when they are in their normal workplace: inside our cells.
“However, the Titan Krios microscopes we have installed in Leeds are absolutely state-of-the-art, and mean that these limitations have been shattered. Researchers and industry users who work with us can now image biological molecules with an incredible resolution. Crucially, we’ll also be able to see how these molecules interact with each other.”
The BK Polyomavirus structure research was funded by Wellcome, Kidney Research UK and Kidney Research Yorkshire.
The top image shows the structure of the virus created by the University's researchers.
Journalists with questions or interview requests, or who would like to visit the University’s cryo-electron microscopy suite, should contact Peter Le Riche in the University of Leeds press office on (+44)113 343 2049 or email firstname.lastname@example.org
Stephen Muench with Glaxo SmithKline & UCB Celltech, BBSRC Industrial Partnership Award (Apr 2018), £480,225
Steve Clapcote, BBSRC (Apr 2018), £443,072
Helen Miller, Innovate UK (Apr 2018), £999,960
Elisabetta Groppelli, David Rowlands & Stanley Lemon (University of North Carolina), Medical Research Foundation Fellowship (Apr 2018), £293,494
Nikesh Patel, Medical Research Foundation fellowship (Apr 2018), £290,976
Graham Askew with colleagues in Hull and Liverpool, BBSRC (Apr 2018), £150,498
Andrew Macdonald, Neil Ranson & Richard Foster, Kidney Research UK (Apr 2018), £82,821
Jessica Kwok & Ralf Richter, Leverhulme Trust (Apr 2018), £298,273
Julie Aspden, Royal Society (Apr 2018), £20,000
Liz Duncan, Royal Society (Mar 2018), £14,602
Alex O'Neill & Ryan Seipke, BBSRC (Feb 2018), £45,489
Jim Deuchars, Royal Society (Feb 2018), £16,300
Stefan Kepinski & Netta Cohen, Leverhulme Trust (Feb 2018), £320,387
Lisa Collins, BBSRC (Feb 2018), £49,950
Alison Baker, BBSRC (Feb 2018), £30,000
Nikita Gamper, BBSRC (Feb 2018), £30,000
Lars Jeuken, BBSRC (Feb 2018), £30,000
Scott Bowen, Leducq Foundation Grant (Feb 2018), £28,470
Jessica Kwok and Ronaldo Ichiyama, International Spinal Research Trust (Feb 2018), £94,450
Alex O'Neill, Oxford Drug Design (Jan 2018), £86,098
Dave Lewis and Colleagues in South Africa, HEFCE Global Challenge Research (Jan 2018), £48,000
Sarah Calaghan, Ed White, John Colyer, Isuru Jayasinghe, BHF (Jan 2018), £128,308
Christine Foyer and Alison Baker, HEFCE GCRF Grant (Jan 2018), £71,158
Alison Baker, Yun Yung Gong and Lindsay Stringer and ICRISAT India, HEFCE GCRF Grant (Jan 2018), £27,000
Graham Askew, Simon Walker, BBSRC (Jan 2018), £699,781
Jennifer Tomlinson, Royal Society (Jan 2018), £512,801
Alison Dunn, NERC (Dec 2017), £18,000
Jennifer Tomlinson, Royal Society-Research Fellows Enhancement Award (Dec 2017), £94,681
Helen Miller, AB AGri Grant (Dec 2017), £73,600
Simon Walker, Royal Society Enhancement Award (Dec 2017), £10,000
Carrie Ferguson, Bryan Taylor, Harry Rossiter, The Physiological Society (Dec 2017), £7,392
Ralf Richter, Royal Society (Dec 2017), £6,000
Christine Foyer, British Council Newton Fund (Dec 2017), £49,840
Adrian Whitehouse and colleagues in School of Chemistry and University of Liverpool, MRC (Nov 2017), £622,319
Michelle Peckham, Neil Ransom, MRC (Nov 2017), £495,159
Dave Lewis, British Council India (Nov 2017), £22,540
Hannah Dugdale, Royal Society (Nov 2017), £15,000
Elton Zeqiraj, Royal Society (Nov 2017), £15,000
Shaunna Burke, Cancer Research UK Innovation Grant (Nov 2017), £20,000
Alex O'Neill and colleagues in Chemistry, BBSRC (Nov 2017), £431,865
Jessica Kwok, Wings for Life (Nov 2017), £87,365
Tom Bennett, BBSRC (Oct 2017), £523,679
Neil Ranson, Darren Tomlinson, BBSRC (Oct 2017), £494,318
Nikita Gamper, BBSRC (Oct 2017), £490,426
Amanda Bretman and colleagues from UEA, NERC (Oct 2017), £430,886
Juan Fontana, Rosetrees Trust consumables grant (Oct 2017), £22,500
Helen Miller, DSM Nutritional Products AG (Sep 2017), £69,988
Neil Ranson, Juan Fontana, Mark Harris, Michelle Peckham, Ralf Richter, Peter Stockley, Patricija Van Oosten-Hawle and colleagues in Engineering, FMH and MAPS, Wellcome Trust Equipment Call (Sep 2017), £418,000
Jamie Johnston, Physiological Society (Sep 2017), £10,000
Frank Sobott, Adrian Goldman, Mark Harris, Andrew Macdonald, Stephen Muench, Sheena Radford and colleagues in FMH and MAPS, Wellcome Trust Equipment Call (Aug 2017), £415,000
Ralf Richter, David Brockwell, Eric Hewitt, Jessica Kwok, Emanuele Paci and MAPS/FMH, BBSRC (Jun 2017), £600,000
Eric Blair, Adrian Whitehouse, Nicola Stonehouse, Alison Baker, Richard Bayliss, Joan Boyes, Ryan Seipke, Sally Boxall and MAPS/FMH, BBSRC (Jun 2017), £376,000
Stefan Kepinski, Yoselin Benitez-Alfonso, Tom Bennett, Michelle Peckham, BBSRC (Jun 2017), £331,000
Roman Tuma, Lars Jeuken, Paul Millner, Sheena Radford, Peter Stockley and MAPS/FMH, BBSRC (Jun 2017), £222,000